rs35073925
Positions:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000272167.10(EPHX1):āc.823A>Gā(p.Thr275Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000481 in 1,614,200 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00062 ( 1 hom., cov: 32)
Exomes š: 0.00047 ( 6 hom. )
Consequence
EPHX1
ENST00000272167.10 missense
ENST00000272167.10 missense
Scores
2
16
Clinical Significance
Conservation
PhyloP100: 4.66
Genes affected
EPHX1 (HGNC:3401): (epoxide hydrolase 1) Epoxide hydrolase is a critical biotransformation enzyme that converts epoxides from the degradation of aromatic compounds to trans-dihydrodiols which can be conjugated and excreted from the body. Epoxide hydrolase functions in both the activation and detoxification of epoxides. Mutations in this gene cause preeclampsia, epoxide hydrolase deficiency or increased epoxide hydrolase activity. Alternatively spliced transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.006364256).
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPHX1 | NM_001136018.4 | c.823A>G | p.Thr275Ala | missense_variant | 6/9 | ENST00000272167.10 | NP_001129490.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPHX1 | ENST00000272167.10 | c.823A>G | p.Thr275Ala | missense_variant | 6/9 | 1 | NM_001136018.4 | ENSP00000272167 | P1 | |
EPHX1 | ENST00000366837.5 | c.823A>G | p.Thr275Ala | missense_variant | 6/9 | 1 | ENSP00000355802 | P1 | ||
EPHX1 | ENST00000614058.4 | c.823A>G | p.Thr275Ala | missense_variant | 6/9 | 1 | ENSP00000480004 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000618 AC: 94AN: 152204Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
94
AN:
152204
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00142 AC: 357AN: 251492Hom.: 4 AF XY: 0.00123 AC XY: 167AN XY: 135920
GnomAD3 exomes
AF:
AC:
357
AN:
251492
Hom.:
AF XY:
AC XY:
167
AN XY:
135920
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000467 AC: 683AN: 1461878Hom.: 6 Cov.: 32 AF XY: 0.000469 AC XY: 341AN XY: 727234
GnomAD4 exome
AF:
AC:
683
AN:
1461878
Hom.:
Cov.:
32
AF XY:
AC XY:
341
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000617 AC: 94AN: 152322Hom.: 1 Cov.: 32 AF XY: 0.000604 AC XY: 45AN XY: 74496
GnomAD4 genome
AF:
AC:
94
AN:
152322
Hom.:
Cov.:
32
AF XY:
AC XY:
45
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
149
Asia WGS
AF:
AC:
21
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hypercholanemia, familial 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 01, 2017 | Likely pathogenicity based on finding it once in our laboratory homozygous in a 9-month-old male with hyperbilirubinemia, hepatosplenomegaly, nephromegaly, hepatic synthetic dysfunction. Heterozygotes would be expected to be asymptomatic carriers. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;.
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Benign
N;.;N
REVEL
Benign
Sift
Benign
T;.;T
Sift4G
Benign
T;T;T
Polyphen
B;B;B
Vest4
MVP
MPC
0.29
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at